Amanda Turkiewicz

New cystic fibrosis treatment approved by US FDA

The US Food and Drug Administration (FDA) approved Vertex’s new drug Orkambi for treatment of cystic fibrosis (CF) on July 2, 2015. This is the first medication specifically intended for CF patients with two copies of a gene mutation known as F508del.

Source - Lung Disease News